mRNA |
Axitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.094 |
0.01 |
mRNA |
ISOX |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.01 |
mRNA |
BX-795 |
GDSC1000 |
pan-cancer |
AAC |
-0.088 |
0.01 |
mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
-0.084 |
0.01 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.01 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.01 |
mRNA |
Crizotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.01 |
mRNA |
AICAR |
GDSC1000 |
pan-cancer |
AAC |
-0.08 |
0.01 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.01 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.02 |